News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Affinium Pharmaceuticals Welcomes Dr. Barry Hafkin as Chief Medical Officer


4/2/2007 12:50:15 PM

TORONTO & AUSTIN, Texas--(BUSINESS WIRE)--Affinium Pharmaceuticals, Inc., a privately held developer of a novel class of highly potent oral antibacterial therapeutics announces the addition of Dr. Barry Hafkin as its Chief Medical Officer. Dr. Hafkin will lead Affinium’s clinical development program and establish Affinium’s new regulatory team based in Austin Texas.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES